首页> 外文OA文献 >Generation of a homology model of the human histamine H₃ receptor for ligand docking and pharmacophore-based screening
【2h】

Generation of a homology model of the human histamine H₃ receptor for ligand docking and pharmacophore-based screening

机译:人类组胺H₃受体同源性模型的产生,用于配体对接和基于药效团的筛选

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The human histamine H₃ receptor (hH₃R) is a G-protein coupled receptor (GPCR), which modulates the release of various neurotransmitters in the central and peripheral nervous system and therefore is a potential target in the therapy of numerous diseases. Although ligands addressing this receptor are already known, the discovery of alternative lead structures represents an important goal in drug design. The goal of this work was to study the hH3R and its antagonists by means of molecular modelling tools. For this purpose, a strategy was pursued in which a homology model of the hH₃R based on the crystal structure of bovine rhodopsin was generated and refined by molecular dynamics simulations in a dipalmitoylphosphatidylcholine (DPPC)/water membrane mimic before the resulting binding pocket was used for high-throughput docking using the program GOLD. Alternatively, a pharmacophore-based procedure was carried out where the alleged bioactive conformations of three different potent hH₃R antagonists were used as templates for the generation of pharmacophore models. A pharmacophore-based screening was then carried out using the program Catalyst. Based upon a database of 418 validated hH₃R antagonists both strategies could be validated in respect of their performance. Seven hits obtained during this screening procedure were commercially purchased, and experimentally tested in a [³H]Nα-methylhistamine binding assay. The compounds tested showed affinities at hH₃R with Ki values ranging from 0.079 to 6.3 lM.
机译:人组胺H +受体(hH + R)是一种G蛋白偶联受体(GPCR),它调节中枢神经系统和周围神经系统中各种神经递质的释放,因此是治疗多种疾病的潜在靶标。尽管解决该受体的配体是已知的,但是发现替代的前导结构代表了药物设计中的重要目标。这项工作的目的是通过分子建模工具研究hH3R及其拮抗剂。为此目的,寻求一种策略,其中基于牛视紫红质的晶体结构生成hH₃R的同源性模型,并通过分子动力学模拟在二棕榈酰磷脂酰胆碱(DPPC)/水膜模拟物中进行建模,然后将所得的结合口袋用于使用程序GOLD进行高通量对接。或者,进行了基于药效团的方法,其中将所称的三种不同的有效hH₃R拮抗剂的生物活性构象用作生成药效团模型的模板。然后使用程序Catalyst进行基于药效团的筛选。基于418种经过验证的hH₃R拮抗剂的数据库,两种策略的性能均可得到验证。该筛选过程中获得的七个命中是商业购买的,并在[3 H]Nα-甲基组胺结合测定中进行了实验测试。测试的化合物在hH = R下显示亲和力,Ki值为0.079至6.3 lM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号